[HTML][HTML] Prevalence and correlates of suicide attempts in high-risk populations: a cross-sectional study among patients receiving opioid agonist therapy in Norway

JH Vold, EM Løberg, CF Aas, JA Steier, KA Johansson… - BMC psychiatry, 2022 - Springer
Background Death by suicide in patients enrolled in opioid agonist therapy (OAT) is a major
clinical concern. However, little knowledge exists regarding suicide attempts in this patient …

Prevalence and correlates of suicide attempts in high-risk populations: a cross-sectional study among patients receiving opioid agonist therapy in Norway

JH Vold, EM Løberg, CF Aas, JA Steier… - BMC …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Death by suicide in patients enrolled in opioid agonist therapy (OAT) is a major
clinical concern. However, little knowledge exists regarding suicide attempts in this patient …

Prevalence and correlates of suicide attempts in high-risk populations: a cross-sectional study among patients receiving opioid agonist therapy in Norway.

JH Vold, EM Løberg, CF Aas, JA Steier… - BMC …, 2022 - search.ebscohost.com
Background: Death by suicide in patients enrolled in opioid agonist therapy (OAT) is a major
clinical concern. However, little knowledge exists regarding suicide attempts in this patient …

Prevalence and correlates of suicide attempts in high-risk populations: a cross-sectional study among patients receiving opioid agonist therapy in Norway.

JH Vold, EM Løberg, CF Aas, JA Steier… - BMC …, 2022 - europepmc.org
Background Death by suicide in patients enrolled in opioid agonist therapy (OAT) is a major
clinical concern. However, little knowledge exists regarding suicide attempts in this patient …

[HTML][HTML] Prevalence and correlates of suicide attempts in high-risk populations: a cross-sectional study among patients receiving opioid agonist therapy in Norway

JH Vold, EM Løberg, CF Aas… - BMC …, 2022 - bmcpsychiatry.biomedcentral.com
Death by suicide in patients enrolled in opioid agonist therapy (OAT) is a major clinical
concern. However, little knowledge exists regarding suicide attempts in this patient group …

Prevalence and correlates of suicide attempts in high-risk populations: a cross-sectional study among patients receiving opioid agonist therapy in Norway

JH Vold, EM Løberg, CF Aas, JA Steier… - BMC psychiatry, 2022 - safetylit.org
BACKGROUND: Death by suicide in patients enrolled in opioid agonist therapy (OAT) is a
major clinical concern. However, little knowledge exists regarding suicide attempts in this …

Prevalence and correlates of suicide attempts in high-risk populations: a cross-sectional study among patients receiving opioid agonist therapy in Norway

JH Vold, EM Løberg, CF Aas, JA Steier, KA Johansson… - 2022 - bora.uib.no
Background Death by suicide in patients enrolled in opioid agonist therapy (OAT) is a major
clinical concern. However, little knowledge exists regarding suicide attempts in this patient …

Prevalence and correlates of suicide attempts in high-risk populations: A cross-sectional study among patients receiving opioid agonist therapy in Norway.

JH Vold, EM Løberg, CF Aas, JA Steier… - BMC …, 2022 - psycnet.apa.org
Background: Death by suicide in patients enrolled in opioid agonist therapy (OAT) is a major
clinical concern. However, little knowledge exists regarding suicide attempts in this patient …

[HTML][HTML] Prevalence and correlates of suicide attempts in high-risk populations: a cross-sectional study among patients receiving opioid agonist therapy in Norway

JH Vold, EM Løberg, CF Aas, JA Steier… - BMC …, 2022 - ncbi.nlm.nih.gov
Background Death by suicide in patients enrolled in opioid agonist therapy (OAT) is a major
clinical concern. However, little knowledge exists regarding suicide attempts in this patient …

Prevalence and correlates of suicide attempts in high-risk populations: a cross-sectional study among patients receiving opioid agonist therapy in Norway

JH Vold, EM Løberg, CF Aas, JA Steier… - BMC psychiatry, 2022 - safetylit.org
BACKGROUND: Death by suicide in patients enrolled in opioid agonist therapy (OAT) is a
major clinical concern. However, little knowledge exists regarding suicide attempts in this …